Company intelligence / Profile preview
Proxi Biotech
Odense, Denmarkproxibiotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Proxi Biotech is a Danish biotechnology company dedicated to developing next-generation vaccines against multi-drug resistant bacterial pathogens. The company utilizes its proprietary ProxiVax™ platform, a "plug-and-display" technology that allows for the rapid and efficient presentation of antigens on the surface of non-pathogenic bacterial scaffolds. This modular approach is designed to induce a potent immune response while maintaining a high safety profile and low manufacturing costs. Currently in the pre-clinical stage, Proxi Biotech is advancing a pipeline of vaccine candidates targeting high-priority pathogens such as Staphylococcus aureus and Group A Streptococcus. The company is a spin-out from the University of Southern Denmark and has received significant support and funding from the BioInnovation Institute.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineRecombinant protein
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Proxi Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Proxi Biotech.